APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vandetanib Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Vandetanib Tablets Market Outlook and Growth Opportunities 2026

27 December 2025195 pages

Choose your research edition.

Industry ResearchVandetanib Tablets Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Vandetanib Tablets Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Vandetanib Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vandetanib Tablets Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Vandetanib Tablets Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Vandetanib Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Vandetanib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Vandetanib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vandetanib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Vandetanib Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Vandetanib Tablets market include Lucius Pharma, AstraZeneca and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Vandetanib Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Vandetanib Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Vandetanib Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Vandetanib Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Vandetanib Tablets Segment by Company

Lucius Pharma

AstraZeneca

Sanofi

Vandetanib Tablets Segment by Type

100mg per Tablet

300mg per Tablet

Vandetanib Tablets Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Vandetanib Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Vandetanib Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Vandetanib Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Vandetanib Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Vandetanib Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vandetanib Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vandetanib Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vandetanib Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Vandetanib Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Vandetanib Tablets industry.

Chapter 3: Detailed analysis of Vandetanib Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Vandetanib Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Vandetanib Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Vandetanib Tablets Industry Trends Table 2. Vandetanib Tablets Industry Drivers Table 3. Vandetanib Tablets Industry Opportunities and Challenges Table 4. Vandetanib Tablets Industry Restraints Table 5. Global Vandetanib Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Vandetanib Tablets Revenue Share by Company (2021-2026) Table 7. Global Vandetanib Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Vandetanib Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Vandetanib Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Vandetanib Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Vandetanib Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Vandetanib Tablets Company, Product Type & Application Table 13. Global Vandetanib Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Vandetanib Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 100mg per Tablet Table 18. Significant Companies of 300mg per Tablet Table 19. Global Vandetanib Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Vandetanib Tablets Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Vandetanib Tablets Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Vandetanib Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Vandetanib Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Vandetanib Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Vandetanib Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Vandetanib Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Vandetanib Tablets Sales Value Share by Type (2021-2026) Table 28. Global Vandetanib Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital and Clinic Table 30. Significant Companies of Retail Pharmacies Table 31. Significant Companies of Other Table 32. Global Vandetanib Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Vandetanib Tablets Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Vandetanib Tablets Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Vandetanib Tablets Sales Volume Share by Application (2021-2026) Table 36. Global Vandetanib Tablets Sales Volume Share by Application (2027-2032) Table 37. Global Vandetanib Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Vandetanib Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Vandetanib Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Vandetanib Tablets Sales Value Share by Application (2021-2026) Table 41. Global Vandetanib Tablets Sales Value Share by Application (2027-2032) Table 42. Global Vandetanib Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Vandetanib Tablets Sales by Region (2021-2026) & (K Units) Table 44. Global Vandetanib Tablets Sales Market Share by Region (2021-2026) Table 45. Global Vandetanib Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Vandetanib Tablets Sales Market Share by Region (2027-2032) Table 47. Global Vandetanib Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Vandetanib Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Vandetanib Tablets Sales Value Share by Region (2021-2026) Table 50. Global Vandetanib Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Vandetanib Tablets Sales Value Share by Region (2027-2032) Table 52. Global Vandetanib Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Vandetanib Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Vandetanib Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Vandetanib Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Vandetanib Tablets Sales by Country (2021-2026) & (K Units) Table 57. Global Vandetanib Tablets Sales Market Share by Country (2021-2026) Table 58. Global Vandetanib Tablets Sales by Country (2027-2032) & (K Units) Table 59. Global Vandetanib Tablets Sales Market Share by Country (2027-2032) Table 60. Global Vandetanib Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Vandetanib Tablets Sales Value Market Share by Country (2021-2026) Table 62. Global Vandetanib Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Vandetanib Tablets Sales Value Market Share by Country (2027-2032) Table 64. Lucius Pharma Company Information Table 65. Lucius Pharma Business Overview Table 66. Lucius Pharma Vandetanib Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Lucius Pharma Vandetanib Tablets Product Portfolio Table 68. Lucius Pharma Recent Development Table 69. AstraZeneca Company Information Table 70. AstraZeneca Business Overview Table 71. AstraZeneca Vandetanib Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. AstraZeneca Vandetanib Tablets Product Portfolio Table 73. AstraZeneca Recent Development Table 74. Sanofi Company Information Table 75. Sanofi Business Overview Table 76. Sanofi Vandetanib Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Sanofi Vandetanib Tablets Product Portfolio Table 78. Sanofi Recent Development Table 79. Key Raw Materials Table 80. Raw Materials Key Suppliers Table 81. Vandetanib Tablets Distributors List Table 82. Vandetanib Tablets Customers List Table 83. Research Programs/Design for This Report Table 84. Authors List of This Report Table 85. Secondary Sources Table 86. Primary Sources List of Figures Figure 1. Vandetanib Tablets Product Image Figure 2. Global Vandetanib Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vandetanib Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Vandetanib Tablets Sales (2021-2032) & (K Units) Figure 5. Global Vandetanib Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Vandetanib Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 100mg per Tablet Image Figure 10. 300mg per Tablet Image Figure 11. Global Vandetanib Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Vandetanib Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Vandetanib Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Vandetanib Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Vandetanib Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Vandetanib Tablets Sales Value Share by Type (2021-2032) Figure 17. Hospital and Clinic Image Figure 18. Retail Pharmacies Image Figure 19. Other Image Figure 20. Global Vandetanib Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Vandetanib Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Vandetanib Tablets Sales Volume Share by Application (2021-2032) Figure 23. Global Vandetanib Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Vandetanib Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Vandetanib Tablets Sales Value Share by Application (2021-2032) Figure 26. Global Vandetanib Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Vandetanib Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Vandetanib Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Vandetanib Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Vandetanib Tablets Sales Value (2021-2032) & (US$ Million) Figure 31. North America Vandetanib Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Vandetanib Tablets Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Vandetanib Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Vandetanib Tablets Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Vandetanib Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Vandetanib Tablets Sales Value (2021-2032) & (US$ Million) Figure 37. South America Vandetanib Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Vandetanib Tablets Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Vandetanib Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Vandetanib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Vandetanib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Vandetanib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Vandetanib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Vandetanib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Vandetanib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Vandetanib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Vandetanib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Vandetanib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Vandetanib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Vandetanib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Vandetanib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Vandetanib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Vandetanib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Vandetanib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Vandetanib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Vandetanib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Vandetanib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Vandetanib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Vandetanib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Vandetanib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Vandetanib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Vandetanib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Vandetanib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Vandetanib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Vandetanib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Vandetanib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Vandetanib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Vandetanib Tablets Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Vandetanib Tablets Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg per Tablet
  • 300mg per Tablet
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Lucius Pharma
  • AstraZeneca
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Vandetanib Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Vandetanib Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Vandetanib Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Vandetanib Tablets Market Dynamics
  1. 2.1 Vandetanib Tablets Industry Trends
  2. 2.2 Vandetanib Tablets Industry Drivers
  3. 2.3 Vandetanib Tablets Industry Opportunities and Challenges
  4. 2.4 Vandetanib Tablets Industry Restraints
3 Vandetanib Tablets Market by Company
  1. 3.1 Global Vandetanib Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Vandetanib Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Vandetanib Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Vandetanib Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Vandetanib Tablets Company Ranking (2024-2026)
  6. 3.6 Global Vandetanib Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Vandetanib Tablets Company Product Type and Application
  8. 3.8 Global Vandetanib Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Vandetanib Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Vandetanib Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Vandetanib Tablets Market by Type
  1. 4.1 Vandetanib Tablets Type Introduction
  2. 4.1.1 100mg per Tablet
  3. 4.1.2 300mg per Tablet
  4. 4.2 Global Vandetanib Tablets Sales Volume by Type
  5. 4.2.1 Global Vandetanib Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Vandetanib Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Vandetanib Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Vandetanib Tablets Sales Value by Type
  9. 4.3.1 Global Vandetanib Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Vandetanib Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Vandetanib Tablets Sales Value Share by Type (2021-2032)
5 Vandetanib Tablets Market by Application
  1. 5.1 Vandetanib Tablets Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Other
  5. 5.2 Global Vandetanib Tablets Sales Volume by Application
  6. 5.2.1 Global Vandetanib Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Vandetanib Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Vandetanib Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Vandetanib Tablets Sales Value by Application
  10. 5.3.1 Global Vandetanib Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Vandetanib Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Vandetanib Tablets Sales Value Share by Application (2021-2032)
6 Vandetanib Tablets Regional Sales and Value Analysis
  1. 6.1 Global Vandetanib Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Vandetanib Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Vandetanib Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Vandetanib Tablets Sales by Region (2027-2032)
  5. 6.3 Global Vandetanib Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Vandetanib Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Vandetanib Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Vandetanib Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Vandetanib Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Vandetanib Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Vandetanib Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Vandetanib Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Vandetanib Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Vandetanib Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Vandetanib Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Vandetanib Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Vandetanib Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Vandetanib Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Vandetanib Tablets Sales Value Share by Country, 2025 VS 2032
7 Vandetanib Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Vandetanib Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Vandetanib Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Vandetanib Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Vandetanib Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Vandetanib Tablets Sales by Country (2027-2032)
  6. 7.4 Global Vandetanib Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Vandetanib Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Vandetanib Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Vandetanib Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Vandetanib Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Vandetanib Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Vandetanib Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Vandetanib Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Vandetanib Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Vandetanib Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Vandetanib Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Vandetanib Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Vandetanib Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Vandetanib Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Vandetanib Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Vandetanib Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Vandetanib Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Vandetanib Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Vandetanib Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Vandetanib Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Vandetanib Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Vandetanib Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Vandetanib Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Vandetanib Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Vandetanib Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Vandetanib Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Vandetanib Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Vandetanib Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Vandetanib Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Vandetanib Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Vandetanib Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Vandetanib Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Vandetanib Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Lucius Pharma
  2. 8.1.1 Lucius Pharma Company Information
  3. 8.1.2 Lucius Pharma Business Overview
  4. 8.1.3 Lucius Pharma Vandetanib Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Lucius Pharma Vandetanib Tablets Product Portfolio
  6. 8.1.5 Lucius Pharma Recent Developments
  7. 8.2 AstraZeneca
  8. 8.2.1 AstraZeneca Company Information
  9. 8.2.2 AstraZeneca Business Overview
  10. 8.2.3 AstraZeneca Vandetanib Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 AstraZeneca Vandetanib Tablets Product Portfolio
  12. 8.2.5 AstraZeneca Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Vandetanib Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Vandetanib Tablets Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Vandetanib Tablets Value Chain Analysis
  2. 9.1.1 Vandetanib Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Vandetanib Tablets Sales Mode & Process
  6. 9.2 Vandetanib Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Vandetanib Tablets Distributors
  9. 9.2.3 Vandetanib Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst